FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

710278000: Idelalisib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3044258013 Idelalisib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3044278017 Idelalisib en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Idelalisib Is a Substance with phosphoinositide 3 kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Idelalisib Has disposition Phosphoinositide 3 kinase inhibitor true Inferred relationship Existential restriction modifier
Idelalisib Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Idelalisib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Idelalisib Is a Amine false Inferred relationship Existential restriction modifier
Idelalisib Is a Purine false Inferred relationship Existential restriction modifier
Idelalisib Is a Quinazoline true Inferred relationship Existential restriction modifier
Idelalisib Is a Fluorine compound false Inferred relationship Existential restriction modifier
Idelalisib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Idelalisib Is a Purine and/or purine derivative true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing idelalisib Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Idelalisib Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing idelalisib in oral dose form (medicinal product form) Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing only idelalisib in oral dose form (medicinal product form) Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing precisely idelalisib 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Idelalisib Inferred relationship Existential restriction modifier 1
Product containing precisely idelalisib 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Idelalisib Inferred relationship Existential restriction modifier 1
Idelalisib 100mg tablets Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Idelalisib 150mg tablets Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences International Ltd) Has specific active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences International Ltd) Has specific active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Idelalisib 150mg tablets 60 tablet Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Idelalisib 100mg tablets 60 tablet Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences Ltd) 60 tablet Has specific active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences Ltd) 60 tablet Has specific active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Idelalisib 100mg tablets Has active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Idelalisib 150mg tablets Has active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences International Ltd) Has active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences International Ltd) Has active ingredient False Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences Ltd) Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences Ltd) Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences Ltd) Has active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences Ltd) Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 100mg tablets (Gilead Sciences Ltd) 60 tablet Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier
Zydelig 150mg tablets (Gilead Sciences Ltd) 60 tablet Has specific active ingredient True Idelalisib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start